Manabu Hishida

Manabu Hishida

Auto-generated profile, based on publicly available information

Manabu Hishida

Kaikoukai Josai Hospital , Nagoya

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
SKShimon Kurasawa
Shimon Kurasawa
MOMasaki Okazaki
Masaki Okazaki
TITakahiro Imaizumi
Takahiro Imaizumi
TKToru Kondo
Toru Kondo
MHManabu Hishida
Manabu Hishida
SMShoichi Maruyama
Shoichi Maruyama
Aims: Aortic valve calcification in aortic sclerosis, a precursor of aortic stenosis (AS), is not always present in all three leaflets; how calcification develops in each leaflet is unknown. We aimed to investigate the natural history of calcification development in each aortic valve leaflet and the prognostic value of the number of calcified leaflets. Methods and results: In a retrospective multicentre cohort study of patients undergoing haemodialysis without AS, we observed calcification development in each aortic valve leaflet using echocardiography. We investigated the association between the number of calcified leaflets and AS development and mortality using time-to-event analysis. Among the 1507 patients (mean age, 66 years; 66% male) included in the longitudinal echocardiography analysis, 709 (47%) had aortic sclerosis at baseline: one-leaflet calcified, 370 (52%); two-leaflet calcified, 215 (30%); and three-leaflet calcified, 124 (17%). The median time for one calcified leaflet increase was 3–4 years, and 251 (17%) patients developed AS during a median 3.2-year follow-up. The increased number of calcified aortic valve leaflets was associated with developing AS; compared with that of one-leaflet calcified, the adjusted hazard ratios (aHRs) [95% confidence intervals (CIs)] of two- and three-leaflet calcified were 2.12 (1.49–3.00) and 4.43 (3.01–6.52), respectively; the aHR (95% CI) per one calcified leaflet increase was 2.24 (1.96–2.55). It was also associated with all-cause mortality; the aHR (95% CI) per one calcified leaflet increase was 1.18 (1.08–1.27). Conclusion: The number of calcified aortic valve leaflets strongly predicted AS development and even mortality in patients undergoing haemodialysis, suggesting the usefulness of assessing calcification for each valve leaflet separately using echocardiography.

10 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MOMasaki Okazaki
Masaki Okazaki
DIDaijo Inaguma
Daijo Inaguma
TITakahiro Imaizumi
Takahiro Imaizumi
MHManabu Hishida
Manabu Hishida
SKShimon Kurasawa
Shimon Kurasawa
SMShoichi Maruyama
Shoichi Maruyama
With the global problem of aging, it has become more difficult to improve the prognosis of older dialysis patients. Extended-hours hemodialysis offers longer treatment time compared to conventional hemodialysis regimen and provides favorable metabolic status, hemodynamic stability, and increased dietary intake. Despite prior studies reporting that in-center extended-hours hemodialysis can reduce the mortality rate, the treatment impact on elderly patients remains unclear. Therefore, we examined the association between extended-hours hemodialysis compared to conventional hemodialysis and all-cause mortality. Survival analyses using Cox proportional hazard model with multivariable adjustments and propensity-score based method were performed to compare mortality risk between 198 consecutive patients who started in-center extended-hours hemodialysis (Extended-HD) and 1407 consecutive patients who initiated conventional hemodialysis. The median age was 67.1 years in the Extended-HD group and 70.7 years in the conventional hemodialysis group. Extended-HD was associated with lower all-cause mortality in overall patients and the subgroup >70 years (adjusted hazard ratios of 0.60 [95% CI, 0.39–0.91] and 0.35 [95% CI, 0.18–0.69], respectively). There was a significant interaction between age >70 years and Extended-HD. In conclusion, extended-hours hemodialysis was associated with a lower mortality rate, especially in elderly patients.

6 May 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
NNNobuhiro Nishibori
Nobuhiro Nishibori
MOMasaki Okazaki
Masaki Okazaki
YMYutaka Miura
Yutaka Miura
MHManabu Hishida
Manabu Hishida
SKShimon Kurasawa
Shimon Kurasawa
SMShoichi Maruyama
Shoichi Maruyama
Extended-hours haemodialysis (HD) is associated with better clinical outcomes than conventional HD. We investigated whether extended-hours HD and conventional HD have varying effects on blood levels of calciprotein particles (CPP) and phosphorus, which have been identified as major pathogenic molecules for vascular calcification. Patients who underwent conventional or extended in-centre daytime HD between January and March 2020 were included. Plasma CPP levels, representing only secondary CPP (CPP-Ⅱ), were measured in pre-dialysis samples. Linear and non-linear associations between CPP and serum phosphorus levels were examined across dialysis modalities. A total of 382 participants (185 undergoing extended-hours HD and 197 undergoing conventional HD) were included in the analysis. The median age of participants was 71 years, 65% of the patients were men, and the mean phosphorus level was 5.4 mg/dL. Plasma CPP (CPP-Ⅱ) levels were lower in the extended-hours HD group than in the conventional HD group (40 018 AU vs. 75 728 AU, p < 0.01). Multivariable linear regression analysis showed that extended-hours HD was associated with lower natural logarithmic plasma CPP (CPP-Ⅱ) levels: -0.64 (95% CI: -0.74 to -0.55). Restricted cubic spline function indicated that extended-hours HD was associated with lower plasma CPP (CPP-Ⅱ) levels across levels of serum phosphorus, with significant differences observed between groups, especially in hyperphosphatemic conditions (P for interaction < 0.01). The extended-hours HD group had lower CPP levels than the conventional HD group despite no significant differences in serum phosphorus levels, which may contribute to better clinical outcomes in patients on extended-hours HD.

23 December 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHManabu Hishida
Manabu Hishida
TSTariq Shafi
Tariq Shafi
LALawrence J Appel
Lawrence J Appel
SMShoichi Maruyama
Shoichi Maruyama
DIDaijo Inaguma
Daijo Inaguma
KMKunihiro Matsushita
Kunihiro Matsushita
Proteinuria is a potent predictor of adverse events in general, although a few large studies have reported a J-shaped association between proteinuria and mortality in individuals with glomerular filtration rate <30 ml/min/1.73m2. However, this association has not been specifically evaluated among incident dialysis patients. Among 1,380 Japanese patients who initiated dialysis, we quantified the association of pre-dialysis dipstick proteinuria (negative/trace, 1+, 2+, and ≥3+) with mortality using Cox models adjusting for potential confounders, such as age, gender, clinical history of hypertension, diabetes, and cardiovascular disease. Mean age of study participants was 67.4 (SD 13.0) years, and 67.6% were men. The most common dipstick proteinuria category was ≥3+ (55.4%), followed by 2+ (31.2%), 1+ (9.9%), and negative or trace (3.5%). Patients with lower proteinuria level were older than those with higher proteinuria. Lower proteinuria was significantly associated with a higher risk of all-cause mortality, even after accounting for potential confounders (p for trend <0.001). In those with negative/trace dipstick proteinuria compared to those with dipstick proteinuria ≥3+, the adjusted hazard ratio was 2.60 [95% CI: 1.62–4.17] in the fully adjusted model. Similar findings were observed when analyses were restricted to patients older than 70 years, and when cardiovascular mortality and non-cardiovascular mortality were analyzed separately. In incident dialysis patients, pre-dialysis proteinuria was inversely associated with mortality risk. Although future studies are needed to identify mechanisms, our findings suggest the need to carefully interpret proteinuria in patients with incident dialysis.

11 September 2025 in Clinical Kidney Journal
Verified
Journal Article
Open access
TITakahiro Imaizumi
Takahiro Imaizumi
MOMasaki Okazaki
Masaki Okazaki
MHManabu Hishida
Manabu Hishida
NNNobuhiro Nishibori
Nobuhiro Nishibori
SKShimon Kurasawa
Shimon Kurasawa
SMShoichi Maruyama
Shoichi Maruyama
Background: Clinical guidelines recommend maintaining ultrafiltration rate (UFR) below 10–13 ml/h/kg for patients undergoing conventional haemodialysis to reduce adverse outcomes. However, achieving this target may compromise nutritional status, particularly in underweight patients. We aimed to explore the association of the interaction between UFR and body weight with mortality. Methods: We analysed the LIBERTY cohort data to assess the association between UFR (net ultrafiltration volume divided by session length) and mortality. We employed three multivariable Cox regression models: baseline (long-term effects), time-dependent (short-term effects), and time-averaged (cumulative effects). Contour plots examined the UFR and post-dialysis weight interactions. Dialysis and laboratory parameters were electronically collected and averaged quarterly. Results: Among 614 patients (mean age 62 years; 65% male) undergoing extended-hours haemodialysis, the median net ultrafiltration volume was 3.0 (IQR, 2.4–3.7) kg/session, with dialysis session length of 21 (18–24) hours/week. The median scaled and unscaled UFR were 7.4 (6.0–9.1) mL/h/kg and 434 (334–531) ml/h, respectively. Over a median follow-up of 6.2 (3.5–10.1) years, 225 patients died. The association between UFR and mortality was significantly modified by post-dialysis weight. Higher-weight patients showed increased mortality with higher UFR in baseline and time-averaged models, while lower-weight patients showed poorer outcomes with lower UFR in time-dependent models. These findings were particularly pronounced in older patients. Conclusion: UFR-mortality association is significantly modified by body weight in extended-hours haemodialysis patients. These findings highlight individualized UFR management needs and potential nutritional intervention benefits for underweight patients.

1 April 2021 in Kidney International Reports
Verified
Journal Article
Open access
MOM. Okazaki
M. Okazaki
TIT. Imaizumi
T. Imaizumi
MHM. Hishida
M. Hishida
SKS. Kurasawa
S. Kurasawa
NNN. Nishibori
N. Nishibori
SMS. Maruyama
S. Maruyama